I use R every day with pretty sensitive data in my county health
department. Of course, this is for manipulation and analysis of data
pulled from their sources, not for interacting directly with, or
updating, patient records in any clinically operational sense. As others
have said, the structure an
No, it was precisely my *point* that Matlab is proprietary.
The medical researchers I knew a few years ago refused to use
R on the grounds that the international agencies they dealt
with all used SAS, which is proprietary. So I am wondering
if "ALL programs that our employees/PROVIDERS use" includ
Ummm...Except that Matlab is proprietary and for profit, not open source.
Did you perhaps mean Octave?
Bert Gunter
"The trouble with having an open mind is that people keep coming along and
sticking things into it."
-- Opus (aka Berkeley Breathed in his "Bloom County" comic strip )
On Thu, Jun
Just as a matter of curiosity, what are some of the programs
that have already been vetted, what methods were used, and
how long did the vetting take?
As the R guidance points out, R was not designed for
creating or updating medical records, so it should be
treated the same way as say LibreOffice
As others have noted, R's vulnerabilities depend on the environments in
which it is used. Perhaps the other issue is whether any downloaded R
software could be problematic, perhaps due to malware. R's core
functionality is, I'm sure fine. For the 20,000 or so packages on CRAN and
elsewhere -- ?? On
You should start by reading
R: Regulatory Compliance and Validation Issues: A guidance document
for the use of R in regulated clinical trial environments.
https://www.r-project.org/doc/R-FDA.pdf
The official link to that file is at the R home page https://www.r-project.org/
In the left column, cli
I work in Pharma and we use R in all the companies I've worked for. They
are really paranoid and it's used in regulated environments as well with
patient data. So there should be something they can do.
Kristin: I can put you in touch with vendors who do our regulated work in R
if you're interested
On 6/18/20 3:41 PM, John Harrold wrote:
Hello Kristin,
Are you talking about risk analysis from the perspective of software
vulnerabilities?
It appears that is exactly what is being asked. What is not clear is
whether the installation would be offered to persons or groups on the
network w
R is open source software that is offered as-is, and many users of R utilize
additional "contributed" packages which are developed and vetted independently
of the R Core members. In addition, it is common for users of R to add minor
functionality in the course of obtaining useful results, which
Hello Kristin,
Are you talking about risk analysis from the perspective of software
vulnerabilities?
John
On Thu, Jun 18, 2020 at 3:21 PM Wait, Kristin wrote:
> HI all,
>
> I am with a NYS major trauma center and all programs that our
> employees/providers use must be vetted through the IT Dep
HI all,
I am with a NYS major trauma center and all programs that our
employees/providers use must be vetted through the IT Department by way of a
Risk Analysis.
Is there someone I would talk to about this?
I scoured your website and could not find a specific person.
Thank you so much
Kristin
Dear Ana
This really depends on your scientific question. The two techniques you
have shown do different things and there must be many more which could
be applied.
Michael
On 17/06/2020 20:57, Ana Marija wrote:
Hello,
I have p values from two distributions, Pold and Pnew
head(m)
CHR
> Ryan Novosielski
> on Wed, 17 Jun 2020 22:04:30 + writes:
> Same story with R-devel 2020-06-16-r78702, everything else the same.
Should I be reporting this someplace else?
Well, maybe Intel? {I've never heard of 'Intel Composer', and
to me it does not look like Free / Ope
13 matches
Mail list logo
